New study questions the validity of publishing hospital mortality ratesSeptember 25, 2007Comparison of hospital episode statistics and central cardiac audit database in public reporting of congenital heart surgery mortality A previous study of mortality rates for congenital heart surgery used routinely available hospital data that were misleading, according to a report published today on bmj.com which questions the validity of such data being made public. Professor Westaby and colleagues found the system of information gathering used in the study had underestimated the number of infant deaths. In the previous BMJ study, published in 2004, Oxford had been singled out as having significantly higher mortality than the national average for open heart surgery on infants. Yet this new paper, using data from a different source - the Central Cardiac Audit Database - shows that the hospital's mortality statistics were not actually different from the mean for all the centres (10 percent compared to 8 percent between 2000 and 2002).
The authors looked at a report from the 'Dr Foster' unit at Imperial College which was published in the wake of the inquiry into the Bristol congenital heart surgery deaths. That inquiry, which drew widespread publicity and had a profound effect on surgical practice in the UK, used Hospital Episode Statistics (HES) to compare mortality rates among cardiac surgical units across the country. The 2004 study by Dr Aylin described these mortality statistics. The authors of the current study compared the mortality rates reported by the administrative HES database and an alternative system, the clinically based Central Cardiac Audit Database, for infants under 12 months undergoing cardiac operations. The statistics were gathered between 1st April 2000 and 31st March 2002. They found HES did not provide reliable patient numbers or 30-day mortality data. On average HES recorded 20 percent fewer cases than CCAD and only captured between 27 percent and 78 percent of 30-day deaths, with a median shortfall of 40 percent. In Centre A, with the largest number of operations, 38 percent of all patients were missed by HES and only 27 percent of the total deaths were recorded. Overall, mortality statistics were underestimated by 4 percent using HES data. The authors say publication of inaccurate statistics detracts from public confidence and that: "If mortality statistics are to be released their quality must be beyond reproach." They acknowledge the media are keen to publish such statistics and pinpoint 'Dr Foster' who have pioneered this by providing newspapers with information on heart disease, for example, in return for a fee. They conclude: "Given the problems with data quality, the imprecision of risk stratification models, and the confrontational agenda in the media, we question the value of placing mortality statistics in the public domain." BMJ-British Medical Journal | |||||||||||||||||||||
|
Related Mortality Rate Current Events and Mortality Rate News Articles Arterial infusion using gabexate mesilate: Is it effective therapy for severe acute pancreatitis? Severe acute pancreatitis (SAP) remains a lethal disease. It is defined as an inflammatory process of the pancreas with possible peripancreatic tissue and multi-organ involvement inducing multi-organ dysfunction syndrome (MODS) with an increased mortality rate. Arterial infusion using gabexate mesilate: Is it effective therapy for severe acute pancreatitis? Severe acute pancreatitis (SAP) remains a lethal disease. It is defined as an inflammatory process of the pancreas with possible peripancreatic tissue and multi-organ involvement inducing multi-organ dysfunction syndrome (MODS) with an increased mortality rate. Activating the lung's antioxidant defense by targeting Nrf2 inhibits the development of emphysema Using a molecule similar to one found in an experimental cancer drug, researchers at the Johns Hopkins Bloomberg School of Public Health demonstrated that activation of a key component of the lung's antioxidant defense system, Nrf2, can prevent emphysema in mice. An ESC statement on gender differences in medical care and survival after myocardial infarction A paper published online by the journal Circulation on 8 December 2008 concluded that, while men and women have a similar in-hospital death rate following acute myocardial infarction, women with STEMI had an adjusted mortality rate almost twice as high as men (10.2% versus 5.5%). Research team explores causes of death on Mount Everest An international research team led by Massachusetts General Hospital (MGH) investigators has conducted the first detailed analysis of deaths during expeditions to the summit of Mt. Everest. Studies examine quality of care for hospitalized sickle cell disease patients A study assessing the quality of care for patients with sickle cell disease in a variety of hospital settings will be presented at a press conference on Saturday, December 6, at 9:30 a.m., during the 50th Annual Meeting of the American Society of Hematology in San Francisco, CA. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. Cardiovascular disease causing increasing inequity between rich and poor A new paper released today by The George Institute for International Health is warning a cardiovascular disease based epidemic is gaining pace among many low- and middle-income countries (LMIC), exemplified at its worst in the world's largest populated countries - China and India. Adult stem cell breakthrough The first tissue-engineered trachea (windpipe), utilising the patient's own stem cells, has been successfully transplanted into a young woman with a failing airway. The bioengineered trachea immediately provided the patient with a normally functioning airway, thereby saving her life. UBC study establishes formula for predicting climate change impact on salmon stocks University of British Columbia researchers have found a way to accurately predict the impact of climate change on imperilled Pacific salmon stocks that could result in better management strategies. More Mortality Rate Current Events and Mortality Rate News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||